Ciclosporin in the Management of Steroid Resistant Type 1 Reactions in Leprosy
Learn more about:
Related Clinical Trial
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2)
Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy
The Effects of Traditional Chinese Medicine Mouthwash Solutions on the Oral Health of Leprosy Patients
The Effect of “Jinchuang Ointment” (JCO) on the Treatment of Wounds in Patients With Hansen’s Disease.
Ciclosporin in the Management of New Erythema Nodosum Leprosum
Effect of Weight and/or Obesity on Dapsone Drug Concentrations
Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum
Treatment of Neuropathic Pain in Leprosy
Montelukast in ENL Reaction
Impact of the Virtual Human Project on Team-based Learning: A Randomized-controlled Trial
Ciclosporin in the Management of Steroid Resistant Type 1 Reactions in Leprosy
Phase 1 LEP-F1 + GLA-SE Vaccine Trial in Healthy Adult Volunteers
CC-11050 Trial in Nepalese Patients With Erythema Nodosum Leprosum
Molecular and Immunological Tools for Detection of Strain Diversity, Drug Resistance and Immunological Responses
Ciclosporin in the Management of New Type 1 Reactions in Leprosy
Uniform Multidrug Therapy Regimen for Leprosy Patients
Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients
Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar
Improved Understanding of Ongoing Transmission of Leprosy in the Hyperendemic Comoros (ComLep)
Molecular Epidemiology of Leprosy – Philippines
Treatment Protocol for Clofazamine in the Long Term Treatment of Leprosy
The Use of Low Level Laser Therapy for Wound Healing in Leprosy Patients
Leprosy Skin Test Antigens Phase 1
Prevention of Disability: Proposal for a Guidance Manual for Leprosy Patients